Select Medical Holdings

Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared in a medically intensive environment, such as a skilled nursing facility. The Rehabilitation Hospital segment provides physical medicine, as well as rehabilitation programs and services, which serve to optimize patient health, function, and quality of life. The Outpatient Rehabilitation segment provides physical, occupational, and speech rehabilitation services through its clinics. The Concentra segment operates through its medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics, which deliver occupational medicine, physical therapy, veteran’s healthcare, and consumer health services. The company was founded by Robert A. Ortenzio and Rocco A. Ortenzio in 1996 and is headquartered in Mechanicsburg, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Select Medical Holdings reports strong Q4 results and growth outlook

Select Medical Holdings demonstrated financial strength and growth potential in Q4 2022 across its divisions.
While challenges like labor market uncertainty persist, opportunities for revenue growth and strategic expansion are evident.
The company's focus on cost management and operational efficiency bodes well for future performance and stakeholder engagement.

Select Medical Holdings posts strong Q1 results, eyes growth

Select Medical Holdings (SEM) reported robust Q1 2023 results, showcasing growth across all divisions and a positive outlook for the year ahead.
The company's focus on cost management, strategic investments, and operational efficiency positions it well for continued success and market expansion.
While facing challenges such as revenue fluctuations and rising interest expenses, Select Medical Holdings remains proactive in addressing operational and financial hurdles.
Opportunities for growth through market expansion, technology utilization, and strategic initiatives underscore a promising trajectory for the company.

Select Medical Holdings reports strong Q2 performance and growth outlook

Select Medical Holdings (SEM) demonstrated robust financial performance in Q2 2023, driven by revenue growth and improved EBITDA across divisions.
The company's strategic refinancing and positive industry recognition position SEM well for future growth and operational excellence.
While facing challenges in maintaining exceptional growth rates, SEM has opportunities to capitalize on its strengths and market positioning for sustained success.

Select Medical Holdings (SEM) reports strong Q3 performance and expansion plans

Select Medical Holdings (SEM) demonstrated robust financial growth in Q3 2023, driven by improvements in various divisions.
The company's focus on expansion through new hospital openings and partnerships presents promising opportunities for future growth.
Overall, Select Medical Holdings (SEM) is well-positioned for continued success and value creation for its shareholders.

Select Medical Holdings reports strong Q4 results and growth opportunities

SEM's strong performance in Q4 2023 and strategic initiatives position the company for growth and value creation.
While facing challenges such as projected start-up losses and increased interest expenses, SEM is actively pursuing opportunities for financial optimization.
The company's focus on separating Concentra, expanding partnerships, and managing capital allocation underscores its commitment to enhancing shareholder value.
Investors should monitor SEM's progress in executing its 2024 outlook and addressing financial challenges to assess future performance.

Select Medical Holdings posts robust Q1 results and outlines growth plans

Select Medical Holdings (SEM) reported strong financial and operational performance in Q1 2024, driven by revenue growth, margin expansion, and strategic initiatives.
While facing challenges in working capital management and capital allocation decisions, SEM's focus on efficiency and growth presents opportunities for value creation and market expansion.
Investors should monitor SEM's progress in executing its growth plans, managing debt levels, and capitalizing on opportunities in the healthcare services sector.

Select Medical Holdings reports solid Q2 performance and expansion plans

Select Medical Holdings delivered a strong Q2 performance with revenue and EBITDA growth across key divisions.
The company's focus on expansion, quality healthcare services, and shareholder returns positions it well for future growth.
While facing challenges like earnings per share decline and regulatory changes, Select Medical has opportunities for market expansion and service enhancement.
Investors should monitor Concentra's performance details and the company's strategic execution in new hospital developments.

Select Medical Holdings reports strong Q3 performance and expansion plans

Select Medical Holdings delivered a robust performance in Q3, with strong revenue and EBITDA growth across all divisions.
The company's expansion plans and strategic projects indicate a focus on long-term growth and market presence.
While facing challenges in managing expansion and financing, Select Medical has opportunities to capitalize on sector growth and operational improvements.
Investors can be optimistic about Select Medical's financial health, demonstrated by the declared cash dividend and positive performance indicators.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following business segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared for in a medically intensive environment, such as a skilled nursing facility. The Rehabilitation Hospital segment provides physical medicine, as well as rehabilitation programs and services, which serve to optimize patient health, function, and quality of life. The Outpatient Rehabilitation segment offers physical, occupational, and speech rehabilitation services through its clinics. The Concentra segment operates through its medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics, which deliver occupational medicine, physical therapy, veteran’s healthcare, and consumer health services. The company was founded by Robert A. Ortenzio and Rocco A. Ortenzio in 1996 and is headquartered in Mechanicsburg, PA.

Select Medical Holdings Corporation (SEM) Management on Q2 2020 Results - Earnings Call Transcript

Select Medical's (SEM) second-quarter earnings performance benefits from lower expenses.

Select Medical's (SEM) Q2 Earnings Beat Estimates, Rise Y/Y

Select Medical (SEM) delivered earnings and revenue surprises of 733.33% and 1.08%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Select Medical (SEM) Q2 Earnings and Revenues Surpass Estimates

MECHANICSBURG, Pa., July 30, 2020 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its second quarter ended June 30, 2020.

Select Medical Holdings Corporation Announces Results For Its Second Quarter Ended June 30, 2020

MECHANICSBURG, Pa., July 9, 2020 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its second quarter ended June 30, 2020 on Thursday, July 30, 2020 after the market closes. Select Medical will host a conference call...

Select Medical Holdings Corporation to Announce Second Quarter 2020 Results on Thursday, July 30

Select Medical (SEM) is well poised to benefit from improved revenues and strong cash flows.

Here's Why Hold Strategy is Apt for Select Medical Stock

Select Medical (SEM) reported earnings 30 days ago. What's next for the stock?

Select Medical (SEM) Down 5.5% Since Last Earnings Report: Can It Rebound?

Select Medical Holdings Corporation (SEM) Management on Q1 2020 Results - Earnings Call Transcript

Select Medical (SEM) delivered earnings and revenue surprises of 12.12% and 2.12%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Select Medical (SEM) Q1 Earnings and Revenues Beat Estimates

Anthem

Centene

Molina Healthcare

HMO Industry: Bullish Near-Term Outlook Despite Coronavirus Impact

Avid Technology

Kirkland Lake Gold

Navient

Sykes Enterprises

Beat the coronavirus blues by investing in these high earnings yield stocks.

5 Stocks With High Earnings Yield to Enhance Your Portfolio

UnitedHealth Group

SEM vs. UNH: Which Stock Is the Better Value Option?

SEM vs. UNH: Which Stock Should Value Investors Buy Now?

ACCO Brands

Alexion Pharma

Blucora

PetIQ

Resideo Technologies Inc

Though price-to-earnings and price-to-sales are the first choices, P/B ratio is also a convenient tool for identifying valuable stocks.

6 Valuable Price-to-Book Stocks to Buy as Recession Lurks

Plagued by business uncertainty from the coronavirus outbreak, Select Medical (SEM) ditches its 2020 earnings guidance.

Select Medical Revokes Full-Year View Amid Coronavirus Blues

Foundation Building Materials

Meritage Homes

Sanmina-SCI

Investment in stocks made on diligent value analysis is usually considered one of the best practices. In value investing, investors pick stocks that are cheap but fundamentally sound.

5 Low P/CF Stocks for a Solid Portfolio Amid Coronavirus Crisis

Humana

SEM vs. HUM: Which Stock Is the Better Value Option?

SEM vs. HUM: Which Stock Should Value Investors Buy Now?

Select Medical (SEM) Down 55.9% Since Last Earnings Report: Can It Rebound?

Joint

HMO players are poised for growth on the back of higher revenues, membership growth, technological advancements and a solid capital position.

3 HMO 2019 Outperformers Likely to Retain Beat Streak in 2020

As of late, it has definitely been a great time to be an investor in Select Medical.

Will Select Medical Continue to Surge Higher?

Select Medical Holdings Corp (SEM) CFO Robert Ortenzio on Q4 2019 Results - Earnings Call Transcript

Select Medical (SEM) delivered earnings and revenue surprises of 55.00% and 2.80%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Select Medical (SEM) Q4 Earnings and Revenues Top Estimates

Select Medical's (SEM) Q4 results are likely to reflect revenue growth across all its segments, increase in expenses and share buyback.

What's in Store for Select Medical's (SEM) Q4 Earnings?

Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Select Medical (SEM) Reports Next Week: What You Should Expect

Select Medical saw its IBD SmartSelect Composite Rating rise to 97 Monday, up from 94 the day before. 
The post Select Medical Receives IBD Stock Rating Upgrade appeared first on Investor's Business Daily.

Select Medical Receives IBD Stock Rating Upgrade

Acquisitions, partnerships and growth in admissions to drive Select Medical's (SEM) performance in 2020.

News for Select Medical Holdings Stock (SEM)